TD Asset Management Inc Acquires 11,782 Shares of McKesson Corporation $MCK

TD Asset Management Inc increased its holdings in shares of McKesson Corporation (NYSE:MCK) by 1.6% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 764,654 shares of the company’s stock after purchasing an additional 11,782 shares during the period. TD Asset Management Inc owned approximately 0.61% of McKesson worth $590,726,000 at the end of the most recent quarter.

Several other institutional investors have also recently added to or reduced their stakes in the business. Solstein Capital LLC lifted its position in shares of McKesson by 171.4% during the 2nd quarter. Solstein Capital LLC now owns 38 shares of the company’s stock valued at $28,000 after acquiring an additional 24 shares during the period. State of Wyoming acquired a new position in shares of McKesson during the second quarter valued at about $29,000. Hopwood Financial Services Inc. acquired a new stake in shares of McKesson in the 3rd quarter valued at about $31,000. Delos Wealth Advisors LLC bought a new stake in McKesson in the 2nd quarter valued at about $35,000. Finally, Abound Wealth Management increased its position in McKesson by 104.3% in the 3rd quarter. Abound Wealth Management now owns 47 shares of the company’s stock valued at $37,000 after buying an additional 24 shares in the last quarter. 85.07% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at McKesson

In other news, Director Maria Martinez sold 349 shares of the stock in a transaction on Thursday, February 19th. The stock was sold at an average price of $939.87, for a total transaction of $328,014.63. Following the completion of the transaction, the director owned 301 shares in the company, valued at approximately $282,900.87. This represents a 53.69% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Leann B. Smith sold 190 shares of the business’s stock in a transaction dated Tuesday, February 17th. The shares were sold at an average price of $945.00, for a total value of $179,550.00. Following the completion of the sale, the executive vice president owned 2,989 shares in the company, valued at $2,824,605. This represents a 5.98% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold 1,143 shares of company stock worth $1,046,070 over the last quarter. 0.08% of the stock is currently owned by corporate insiders.

McKesson News Summary

Here are the key news stories impacting McKesson this week:

• Positive Sentiment: Brokerages maintain a constructive view — McKesson has a consensus “Moderate Buy” from analysts, supporting demand and providing a bullish backdrop for the shares. McKesson Corporation (NYSE:MCK) Receives Consensus Rating of “Moderate Buy” from Brokerages
• Positive Sentiment: Growth markets bolster medium-term thesis — McKesson is named among top players in a Radiology Information System market report that projects strong CAGR and expansion of health‑IT spend, which supports its software/technology franchise and recurring revenue potential. Radiology Information System Market Competitive Landscape Report 2025
• Positive Sentiment: Analyst coverage and investor interest remain elevated — media pieces highlighting Wall Street support and analyst upgrades keep attention on MCK and can drive buying from momentum and institutional flows. Wall Street Analysts Think McKesson (MCK) Is a Good Investment: Is It?
• Neutral Sentiment: Dividend and institutional positioning are stable — MarketBeat coverage reiterates a modest dividend and heavy institutional ownership, which supports steady demand but limits volatility. McKesson stock profile and recent MarketBeat coverage
• Negative Sentiment: Governance probe raises dilution concerns — Faruqi & Faruqi opened an investigation into the board’s recommendation to approve a large share issuance, spotlighting potential shareholder dilution and governance risk that could pressure sentiment. Faruqi Review Of McKesson Share Plan Puts Dilution And Governance In Focus
• Negative Sentiment: Insider selling adds short-term caution — A director sold ~349 shares (~$328k), reducing her stake significantly; while the size is modest for a large-cap, such sales can be interpreted negatively by short-term traders. McKesson (NYSE:MCK) Director Sells $328,014.63 in Stock
• Negative Sentiment: Analyst caution on upside — Commentary (e.g., Seeking Alpha) notes strong recent earnings but suggests upside may be exhausted, which can cap near-term multiple expansion. McKesson Corporation: Strong Q3 Earnings But Upside Exhausted

McKesson Stock Performance

NYSE MCK opened at $957.77 on Wednesday. The company has a market capitalization of $117.32 billion, a PE ratio of 27.55, a price-to-earnings-growth ratio of 1.53 and a beta of 0.40. McKesson Corporation has a 52-week low of $601.45 and a 52-week high of $971.93. The company has a 50-day simple moving average of $859.11 and a 200 day simple moving average of $801.04.

McKesson (NYSE:MCK) last released its earnings results on Wednesday, February 4th. The company reported $9.34 earnings per share for the quarter, beating analysts’ consensus estimates of $9.19 by $0.15. McKesson had a net margin of 1.09% and a negative return on equity of 338.97%. The firm had revenue of $106.16 billion during the quarter, compared to the consensus estimate of $105.98 billion. During the same period in the prior year, the firm earned $8.03 EPS. The company’s revenue was up 11.4% compared to the same quarter last year. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. As a group, analysts forecast that McKesson Corporation will post 32.77 EPS for the current fiscal year.

McKesson Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, April 1st. Shareholders of record on Monday, March 2nd will be paid a $0.82 dividend. The ex-dividend date is Monday, March 2nd. This represents a $3.28 annualized dividend and a dividend yield of 0.3%. McKesson’s payout ratio is presently 9.43%.

Wall Street Analyst Weigh In

Several brokerages recently weighed in on MCK. Robert W. Baird set a $968.00 price target on shares of McKesson in a research report on Wednesday, January 14th. UBS Group lifted their target price on McKesson from $920.00 to $980.00 and gave the company a “buy” rating in a research report on Thursday, November 6th. Evercore reaffirmed an “outperform” rating and set a $1,000.00 price objective on shares of McKesson in a report on Thursday, November 6th. JPMorgan Chase & Co. increased their target price on shares of McKesson from $983.00 to $1,107.00 and gave the company an “overweight” rating in a report on Tuesday, February 10th. Finally, Wall Street Zen lowered shares of McKesson from a “buy” rating to a “hold” rating in a research note on Saturday, November 8th. Thirteen equities research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the stock. According to MarketBeat, McKesson has an average rating of “Moderate Buy” and a consensus target price of $943.50.

McKesson Company Profile

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.